In this study, we discovered CPEB1 as a key regulator controlling NRF2 proteostasis and ferroptosis susceptibility in pancreatic cancer, and established the clinical significance of CPEB1 in predicting therapeutic outcomes. This evidence concerns the gene CPEB1 and pancreatic neoplasm.